Citracal Slow Release 1200
Bayer Citracal Slow Release 1200 is an 'Other Combinations' supplement focused on bone health, containing 4 ingredients. It provides clinically relevant doses of Vitamin D (1000IU) and Calcium (1200mg), both essential for bone density and calcium absorption. However, the 80mg of Magnesium is underdosed compared to common clinical recommendations for standalone supplementation. The product offers full label transparency for its listed ingredients. With an N+ Score of 67 and a C- grade, it is considered an average-tier product. It may be beneficial for individuals seeking robust calcium and vitamin D support for bone health.
About This Product
Citracal Slow Release 1200 by Bayer Citracal is a joint & bone supplement containing 4 active ingredients. It has earned an N+ Score of 67/100 (Grade C-).
Notable clinical-dose ingredients include Vitamin D, Calcium.
N+ Score Breakdown
Are key ingredients present at clinically effective doses based on research?
Does the product include all expected ingredients for its supplement category?
Are individual ingredient amounts clearly disclosed without proprietary blends?
Does the formula include a breadth of beneficial compounds from multiple pathways?
Strengths
- +Fully transparent label with individual ingredient amounts disclosed
- +Broad ingredient diversity exceeding category norms
- +2 ingredient(s) at clinical dose levels
Weaknesses
- −Missing several expected ingredients for its category
Ingredient Analysis (4 ingredients)
| Ingredient | Amount | Dose Adequacy |
|---|---|---|
| Vitamin D | 1000.000 IU | Optimal |
| Calcium | 1200.000 mg | Optimal |
| Magnesium | 80.000 mg | Under |
| Sodium | 5.000 mg | N/A |
Clinical ranges based on NIH ODS Fact Sheets and peer-reviewed research. Status indicates whether the amount meets evidence-based thresholds.